Testing for Vitamin C Levels: Clinical Utility
Plasma vitamin C testing is clinically useful only in specific situations—when you suspect scurvy or chronic low intake—but should NOT be ordered in critically ill or inflamed patients where results are uninterpretable. 1
When to Test
Test plasma vitamin C in these scenarios:
- Clinical suspicion of scurvy (bleeding gums, petechiae, poor wound healing, perifollicular hemorrhages)
- Suspected chronic low intake (severe dietary restriction, malabsorption syndromes, alcoholism)
- High-risk populations without acute illness (bariatric surgery patients, chronic malabsorption, severe dietary restriction)
Do NOT test in these situations:
Measurement of plasma vitamin C is not recommended in critical illness or severe inflammation due to difficulty in interpretation of results 1. This is a critical pitfall—vitamin C plasma levels decline rapidly when CRP >10 mg/L, and normal values are essentially never detected when CRP >40 mg/L 1. The low levels reflect acute inflammatory consumption rather than true body stores, making the test clinically meaningless in these contexts.
Clinical Decision Algorithm
If you suspect vitamin C deficiency based on clinical signs:
- Don't wait for lab results—start empiric treatment immediately with approximately 1 g/day of vitamin C for at least one week 1
- Consider testing only if diagnosis is uncertain AND patient has no active inflammation (check CRP first)
- If CRP >10 mg/L, skip the vitamin C test entirely and treat empirically based on clinical suspicion
Why Testing Has Limited Utility
The fundamental problem is that no reliable functional biomarkers exist for vitamin C status 2. We're stuck measuring plasma concentrations, which:
- Don't reliably reflect tissue stores 3
- Are profoundly affected by inflammation 1
- Require specialized handling (immediate acidification, cold storage, protection from oxidation) 1
- Are technically challenging for most hospital laboratories 4
Specific High-Risk Groups Warranting Consideration
In non-inflamed patients with these conditions, testing may guide supplementation:
- Diabetes mellitus
- Heart failure
- Chronic smokers
- Alcoholism
- Severe COPD
- Chronic dialysis patients
These patients have chronic oxidative stress and may benefit from 200-500 mg/day supplementation regardless of testing 1.
Key Caveats
The most important clinical pitfall: Ordering vitamin C levels in hospitalized or acutely ill patients. The results will almost always be low due to inflammatory consumption, leading to misinterpretation and unnecessary concern. In critically ill patients, plasma vitamin C concentrations are associated with oxidative stress severity, organ failure, and mortality 1—but these low levels don't indicate chronic deficiency requiring long-term supplementation; they indicate acute consumption requiring high-dose IV repletion (2-3 g/day) during the acute phase 1.
Bottom line: In real-world clinical practice, vitamin C testing has extremely limited utility. If clinical signs suggest deficiency, treat empirically. If the patient is acutely ill or inflamed, don't test at all—the results won't guide management.